Cargando…
Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo
Human T-lymphotropic Virus-1 (HTLV-1) is a retrovirus that persists lifelong by driving clonal proliferation of infected T-cells. HTLV-1 causes a neuroinflammatory disease and adult T-cell leukemia/lymphoma. Strongyloidiasis, a gastrointestinal infection by the helminth Strongyloides stercoralis, an...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617147/ https://www.ncbi.nlm.nih.gov/pubmed/23592987 http://dx.doi.org/10.1371/journal.ppat.1003263 |
_version_ | 1782265225381150720 |
---|---|
author | Gillet, Nicolas A. Cook, Lucy Laydon, Daniel J. Hlela, Carol Verdonck, Kristien Alvarez, Carolina Gotuzzo, Eduardo Clark, Daniel Farré, Lourdes Bittencourt, Achiléa Asquith, Becca Taylor, Graham P. Bangham, Charles R. M. |
author_facet | Gillet, Nicolas A. Cook, Lucy Laydon, Daniel J. Hlela, Carol Verdonck, Kristien Alvarez, Carolina Gotuzzo, Eduardo Clark, Daniel Farré, Lourdes Bittencourt, Achiléa Asquith, Becca Taylor, Graham P. Bangham, Charles R. M. |
author_sort | Gillet, Nicolas A. |
collection | PubMed |
description | Human T-lymphotropic Virus-1 (HTLV-1) is a retrovirus that persists lifelong by driving clonal proliferation of infected T-cells. HTLV-1 causes a neuroinflammatory disease and adult T-cell leukemia/lymphoma. Strongyloidiasis, a gastrointestinal infection by the helminth Strongyloides stercoralis, and Infective Dermatitis associated with HTLV-1 (IDH), appear to be risk factors for the development of HTLV-1 related diseases. We used high-throughput sequencing to map and quantify the insertion sites of the provirus in order to monitor the clonality of the HTLV-1-infected T-cell population (i.e. the number of distinct clones and abundance of each clone). A newly developed biodiversity estimator called “DivE” was used to estimate the total number of clones in the blood. We found that the major determinant of proviral load in all subjects without leukemia/lymphoma was the total number of HTLV-1-infected clones. Nevertheless, the significantly higher proviral load in patients with strongyloidiasis or IDH was due to an increase in the mean clone abundance, not to an increase in the number of infected clones. These patients appear to be less capable of restricting clone abundance than those with HTLV-1 alone. In patients co-infected with Strongyloides there was an increased degree of oligoclonal expansion and a higher rate of turnover (i.e. appearance and disappearance) of HTLV-1-infected clones. In Strongyloides co-infected patients and those with IDH, proliferation of the most abundant HTLV-1(+) T-cell clones is independent of the genomic environment of the provirus, in sharp contrast to patients with HTLV-1 infection alone. This implies that new selection forces are driving oligoclonal proliferation in Strongyloides co-infection and IDH. We conclude that strongyloidiasis and IDH increase the risk of development of HTLV-1-associated diseases by increasing the rate of infection of new clones and the abundance of existing HTLV-1(+) clones. |
format | Online Article Text |
id | pubmed-3617147 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-36171472013-04-16 Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo Gillet, Nicolas A. Cook, Lucy Laydon, Daniel J. Hlela, Carol Verdonck, Kristien Alvarez, Carolina Gotuzzo, Eduardo Clark, Daniel Farré, Lourdes Bittencourt, Achiléa Asquith, Becca Taylor, Graham P. Bangham, Charles R. M. PLoS Pathog Research Article Human T-lymphotropic Virus-1 (HTLV-1) is a retrovirus that persists lifelong by driving clonal proliferation of infected T-cells. HTLV-1 causes a neuroinflammatory disease and adult T-cell leukemia/lymphoma. Strongyloidiasis, a gastrointestinal infection by the helminth Strongyloides stercoralis, and Infective Dermatitis associated with HTLV-1 (IDH), appear to be risk factors for the development of HTLV-1 related diseases. We used high-throughput sequencing to map and quantify the insertion sites of the provirus in order to monitor the clonality of the HTLV-1-infected T-cell population (i.e. the number of distinct clones and abundance of each clone). A newly developed biodiversity estimator called “DivE” was used to estimate the total number of clones in the blood. We found that the major determinant of proviral load in all subjects without leukemia/lymphoma was the total number of HTLV-1-infected clones. Nevertheless, the significantly higher proviral load in patients with strongyloidiasis or IDH was due to an increase in the mean clone abundance, not to an increase in the number of infected clones. These patients appear to be less capable of restricting clone abundance than those with HTLV-1 alone. In patients co-infected with Strongyloides there was an increased degree of oligoclonal expansion and a higher rate of turnover (i.e. appearance and disappearance) of HTLV-1-infected clones. In Strongyloides co-infected patients and those with IDH, proliferation of the most abundant HTLV-1(+) T-cell clones is independent of the genomic environment of the provirus, in sharp contrast to patients with HTLV-1 infection alone. This implies that new selection forces are driving oligoclonal proliferation in Strongyloides co-infection and IDH. We conclude that strongyloidiasis and IDH increase the risk of development of HTLV-1-associated diseases by increasing the rate of infection of new clones and the abundance of existing HTLV-1(+) clones. Public Library of Science 2013-04-04 /pmc/articles/PMC3617147/ /pubmed/23592987 http://dx.doi.org/10.1371/journal.ppat.1003263 Text en © 2013 Gillet et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Gillet, Nicolas A. Cook, Lucy Laydon, Daniel J. Hlela, Carol Verdonck, Kristien Alvarez, Carolina Gotuzzo, Eduardo Clark, Daniel Farré, Lourdes Bittencourt, Achiléa Asquith, Becca Taylor, Graham P. Bangham, Charles R. M. Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo |
title | Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo
|
title_full | Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo
|
title_fullStr | Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo
|
title_full_unstemmed | Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo
|
title_short | Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo
|
title_sort | strongyloidiasis and infective dermatitis alter human t lymphotropic virus-1 clonality in vivo |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617147/ https://www.ncbi.nlm.nih.gov/pubmed/23592987 http://dx.doi.org/10.1371/journal.ppat.1003263 |
work_keys_str_mv | AT gilletnicolasa strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT cooklucy strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT laydondanielj strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT hlelacarol strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT verdonckkristien strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT alvarezcarolina strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT gotuzzoeduardo strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT clarkdaniel strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT farrelourdes strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT bittencourtachilea strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT asquithbecca strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT taylorgrahamp strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT banghamcharlesrm strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo |